Evidence map›Paper›PMID 28494771›Full record

ArticleOrphanet journal of rare diseases2017

Probable DRESS syndrome induced by IL-1 inhibitors.

L Polivka, J S Diana, A Soria, C Bodemer, P Quartier, S Fraitag, B Bader-Meunier

Open access · goldAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Orphanet journal of rare diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

L PolivkaParis Descartes-Sorbonne Paris Cité University and IMAGINE Institute, Paris, France.
J S DianaParis Descartes-Sorbonne Paris Cité University and IMAGINE Institute, Paris, France.
A SoriaSorbonne University, UPMC University Paris 06, Immunology and Infectious diseases Center - Paris (Cimi-Paris), INSERM U1135, Paris, France.
C BodemerParis Descartes-Sorbonne Paris Cité University and IMAGINE Institute, Paris, France.
P QuartierParis Descartes-Sorbonne Paris Cité University and IMAGINE Institute, Paris, France.
S FraitagParis Descartes-Sorbonne Paris Cité University and IMAGINE Institute, Paris, France.
B Bader-MeunierParis Descartes-Sorbonne Paris Cité University and IMAGINE Institute, Paris, France. brigitte.bader-meunier@aphp.fr.
Hôpital Necker-Enfants Malades · FRSorbonne Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRCentre d'Immunologie et des Maladies Infectieuses · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL)-1 inhibitors have been increasingly used for treating autoinflammatory diseases during the last 10 years, but the spectrum of their possible side effects is not yet fully known. Here, we bring physicians' attention to a new severe complication of IL-1 inhibitors, manifesting as a probable drug reaction with eosinophilia and systemic symptoms (DRESS) in two patients.

Indexed as

AnimalsDrug Hypersensitivity SyndromeFemaleHereditary Autoinflammatory DiseasesHistocompatibility TestingHumansInterleukin-1Receptors, Interleukin-1Interleukin-1Receptors, Interleukin-1Autoinflammatory diseaseDRESSIL-1 inhibitors

Identifiers

PMID28494771
PMCPMC5425965
OpenAlexW2612989699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.